Cargando…

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy

Cerebral amyloid angiopathy (CAA) is a common cause of lobar intracerebral hemorrhage (ICH) in elderly individuals and it is the result of the cerebrovascular deposition of beta-amyloid (Aβ) protein. CAA is frequently found in patients with Alzheimer's disease (AD), although it has an independe...

Descripción completa

Detalles Bibliográficos
Autores principales: Camacho, Jessica, Moliné, Teresa, Bonaterra-Pastra, Anna, Ramón y Cajal, Santiago, Martínez-Sáez, Elena, Hernández-Guillamon, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424885/
https://www.ncbi.nlm.nih.gov/pubmed/30918495
http://dx.doi.org/10.3389/fneur.2019.00187
_version_ 1783404735848513536
author Camacho, Jessica
Moliné, Teresa
Bonaterra-Pastra, Anna
Ramón y Cajal, Santiago
Martínez-Sáez, Elena
Hernández-Guillamon, Mar
author_facet Camacho, Jessica
Moliné, Teresa
Bonaterra-Pastra, Anna
Ramón y Cajal, Santiago
Martínez-Sáez, Elena
Hernández-Guillamon, Mar
author_sort Camacho, Jessica
collection PubMed
description Cerebral amyloid angiopathy (CAA) is a common cause of lobar intracerebral hemorrhage (ICH) in elderly individuals and it is the result of the cerebrovascular deposition of beta-amyloid (Aβ) protein. CAA is frequently found in patients with Alzheimer's disease (AD), although it has an independent contribution to the cognitive deterioration associated with age. Specific apolipoproteins (Apo) have been associated with Aβ fibrillization and clearance from the brain. In this regard, in the present study, we analyzed the brain levels of ApoE, ApoA-I, and ApoJ/clusterin in autopsy brains from 20 post-mortem cases with CAA type I, CAA type II, with parenchymal Aβ deposits or without Aβ deposits. Our objective was to find a possible differential pattern of apolipoproteins distribution in the brain depending on the CAA pathological presentation. The protein expression levels were adjusted by the APOE genotype of the patients included in the study. We found that ApoE and ApoJ were abundantly present in meningeal, cortical, and capillary vessels of the brains with vascular Aβ accumulation. ApoE and ApoJ also deposited extracellularly in the parenchyma, especially in cases presenting Aβ diffuse and neuritic parenchymal deposits. In contrast, ApoA-I staining was only relevant in capillary walls in CAA type I cases. On the other hand, ICH was the principal cause of death among CAA patients in our cohort. We found that CAA patients with ICH more commonly had APOEε2 compared with CAA patients without ICH. In addition, patients who suffered an ICH presented higher vascular ApoE levels in brain. However, higher ApoE presence in cortical arteries was the only independent predictor of suffering an ICH in our cohort after adjusting by age and APOE genotype. In conclusion, while ApoE and ApoJ appear to be involved in both vascular and parenchymal Aβ pathology, ApoA-I seems to be mainly associated with CAA, especially in CAA type I pathology. We consider that our study helps to molecularly characterize the distribution subtypes of Aβ deposition within the brain.
format Online
Article
Text
id pubmed-6424885
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64248852019-03-27 Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy Camacho, Jessica Moliné, Teresa Bonaterra-Pastra, Anna Ramón y Cajal, Santiago Martínez-Sáez, Elena Hernández-Guillamon, Mar Front Neurol Neurology Cerebral amyloid angiopathy (CAA) is a common cause of lobar intracerebral hemorrhage (ICH) in elderly individuals and it is the result of the cerebrovascular deposition of beta-amyloid (Aβ) protein. CAA is frequently found in patients with Alzheimer's disease (AD), although it has an independent contribution to the cognitive deterioration associated with age. Specific apolipoproteins (Apo) have been associated with Aβ fibrillization and clearance from the brain. In this regard, in the present study, we analyzed the brain levels of ApoE, ApoA-I, and ApoJ/clusterin in autopsy brains from 20 post-mortem cases with CAA type I, CAA type II, with parenchymal Aβ deposits or without Aβ deposits. Our objective was to find a possible differential pattern of apolipoproteins distribution in the brain depending on the CAA pathological presentation. The protein expression levels were adjusted by the APOE genotype of the patients included in the study. We found that ApoE and ApoJ were abundantly present in meningeal, cortical, and capillary vessels of the brains with vascular Aβ accumulation. ApoE and ApoJ also deposited extracellularly in the parenchyma, especially in cases presenting Aβ diffuse and neuritic parenchymal deposits. In contrast, ApoA-I staining was only relevant in capillary walls in CAA type I cases. On the other hand, ICH was the principal cause of death among CAA patients in our cohort. We found that CAA patients with ICH more commonly had APOEε2 compared with CAA patients without ICH. In addition, patients who suffered an ICH presented higher vascular ApoE levels in brain. However, higher ApoE presence in cortical arteries was the only independent predictor of suffering an ICH in our cohort after adjusting by age and APOE genotype. In conclusion, while ApoE and ApoJ appear to be involved in both vascular and parenchymal Aβ pathology, ApoA-I seems to be mainly associated with CAA, especially in CAA type I pathology. We consider that our study helps to molecularly characterize the distribution subtypes of Aβ deposition within the brain. Frontiers Media S.A. 2019-03-13 /pmc/articles/PMC6424885/ /pubmed/30918495 http://dx.doi.org/10.3389/fneur.2019.00187 Text en Copyright © 2019 Camacho, Moliné, Bonaterra-Pastra, Ramón y Cajal, Martínez-Sáez and Hernández-Guillamon. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Camacho, Jessica
Moliné, Teresa
Bonaterra-Pastra, Anna
Ramón y Cajal, Santiago
Martínez-Sáez, Elena
Hernández-Guillamon, Mar
Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
title Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
title_full Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
title_fullStr Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
title_full_unstemmed Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
title_short Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
title_sort brain apoa-i, apoj and apoe immunodetection in cerebral amyloid angiopathy
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424885/
https://www.ncbi.nlm.nih.gov/pubmed/30918495
http://dx.doi.org/10.3389/fneur.2019.00187
work_keys_str_mv AT camachojessica brainapoaiapojandapoeimmunodetectionincerebralamyloidangiopathy
AT molineteresa brainapoaiapojandapoeimmunodetectionincerebralamyloidangiopathy
AT bonaterrapastraanna brainapoaiapojandapoeimmunodetectionincerebralamyloidangiopathy
AT ramonycajalsantiago brainapoaiapojandapoeimmunodetectionincerebralamyloidangiopathy
AT martinezsaezelena brainapoaiapojandapoeimmunodetectionincerebralamyloidangiopathy
AT hernandezguillamonmar brainapoaiapojandapoeimmunodetectionincerebralamyloidangiopathy